The American Society of Gene and Cell Therapy (ASGCT) will be hosting their 2020 Policy Summit virtually to cover regulatory, government relations, market access, and ethical issues over 2.5 days. Eric Faulkner, Vice President, Real-World Value and Strategy, and Executive Director, Center of Excellence – Precision and Transformative Medicine, will be discussing evidence-generation solutions to support regulatory and payer requirements during his panel on Thursday, September 24th, from 1:00 – 2:30pm.

Conference Website